Yourgene Health PLC (LON:YGEN) rose 0.4% during trading on Thursday . The stock traded as high as GBX 11.55 ($0.15) and last traded at GBX 11.55 ($0.15), approximately 90,097 shares changed hands during trading. The stock had previously closed at GBX 11.50 ($0.15).
The stock has a market cap of $68.89 million and a P/E ratio of 12.78. The company has a fifty day moving average price of GBX 11.44 and a 200 day moving average price of GBX 11.78. The company has a debt-to-equity ratio of 2.67, a current ratio of 1.25 and a quick ratio of 0.94.
In other news, insider Hayden Jeffreys acquired 83,512 shares of the firm’s stock in a transaction dated Wednesday, July 31st. The stock was purchased at an average price of GBX 12 ($0.16) per share, for a total transaction of £10,021.44 ($13,094.79).
Yourgene Health Plc, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom and internationally. The company develops the IONA Test, an in vitro diagnostic non-invasive pre-natal screening test for pregnant women to estimate Down's syndrome, Edward's syndrome, and Patau's syndrome.
Further Reading: Purposes and Functions of the Federal Reserve
Receive News & Ratings for Yourgene Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yourgene Health and related companies with MarketBeat.com's FREE daily email newsletter.